Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-039638
Filing Date
2021-06-10
Accepted
2021-06-10 19:02:10
Documents
2
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7836
2 POA DOCUMENT poa.txt EX-24.3_991968 3047
  Complete submission text file 0001209191-21-039638.txt   12269
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address
Campbell David Alan (Reporting) CIK: 0001864158 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40475 | Film No.: 211009470